Evidence map›Paper›PMID 18270823›Full record

ArticleNeurochemical research2008

Presynaptic modulation by somatostatin in the neostriatum.

Violeta Gisselle Lopez-Huerta, Fatuel Tecuapetla, Jaime N Guzman, Jose Bargas, Elvira Galarraga

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Neuropeptidergic systems in psychiatric disorders.Frontiers in endocrinology · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. A novel functionally distinct subtype of striatal neuropeptide Y interneuron.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
  14. Article
  15. Distinct roles of GABAergic interneurons in the regulation of striatal output pathways.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2010
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Violeta Gisselle Lopez-HuertaDepartamento de Biofísica, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, PO Box 70-253, Mexico City, DF, 04510, Mexico.
Fatuel Tecuapetla
Jaime N Guzman
Jose Bargas
Elvira Galarraga
Universidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medium spiny projection neurons (MSNs) are the main neuronal population in the neostriatum. MSNs are inhibitory and GABAergic. MSNs connect with other MSNs via local axon collaterals that produce lateral inhibition, which is thought to select cell assemblies for motor action. MSNs also receive inhibitory inputs from GABAergic local interneurons. This work shows, through the use of the paired pulse protocol, that somatostatin (SST) acts presynaptically to regulate GABA release from the terminals interconnecting MSNs. This SST action is reversible and not mediated through the release of dopamine. It is blocked by the SST receptor (SSTR) antagonist ciclosomatostatin (cicloSST). In contrast, SST does not regulate inhibition coming from interneurons. Because, SST is released by a class of local interneuron, it is concluded that this neuron helps to regulate the selection of motor acts.

Indexed as

6-Cyano-7-nitroquinoxaline-2,3-dioneAction Potentialsalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic AcidAnimalsCorpus StriatumExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsInhibitory Postsynaptic PotentialsNeuronsN-MethylaspartatePatch-Clamp TechniquesPresynaptic TerminalsRatsRats, WistarSomatostatinValine2-amino-5-phosphopentanoic acid6-Cyano-7-nitroquinoxaline-2,3-dionealpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic AcidExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsN-MethylaspartateSomatostatinValine

Identifiers

PMID18270823
OpenAlexW1966635187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.